Clinical Trial Update: Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis [NA]

View source ↗

Summary

A clinical trial update describes a combination therapy of platelet-rich plasma (PRP) and cross-linked hyaluronic acid (XLHA) prepared with the RegenMatrix devi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cross-linked hyaluronic acid (XLHA) (cross-linked hyaluronic acid)
• Platelet-rich plasma (PRP)

Snippet

Sponsor: RegenLab France SAS | Conditions: Knee Osteoarthritis | NA | Status: ACTIVE_NOT_RECRUITING